Viewing Study NCT00078195


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2025-12-29 @ 6:39 AM
Study NCT ID: NCT00078195
Status: COMPLETED
Last Update Posted: 2016-10-18
First Post: 2004-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: DAIT ITN019AD
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View